Dynavax (DVAX) Misses Q1 EPS by 81c, Misses on Revenue

Dynavax (NASDAQ: DVAX) reported Q1 EPS of ($0.77), $0.81 worse than the analyst estimate of $0.04. Revenue for the quarter came in at $65 million versus the consensus estimate of $67.86 million.

For earnings history and earnings-related data on Dynavax (DVAX) click here.

You May Also Be Interested In

• Tesla Crash Into Texas Home Now Under Federal Safety Probe - WSJ
• Primoris cuts 2026 outlook on renewables cost overruns, COO exits
• MacroGenics to receive $24.5M milestone from Sanofi on FDA approval